» Articles » PMID: 35842634

TA-MSCs, TA-MSCs-EVs, MIF: Their Crosstalk in Immunosuppressive Tumor Microenvironment

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2022 Jul 16
PMID 35842634
Authors
Affiliations
Soon will be listed here.
Abstract

As an important component of the immunosuppressive tumor microenvironment (TME), it has been established that mesenchymal stem cells (MSCs) promote the progression of tumor cells. MSCs can directly promote the proliferation, migration, and invasion of tumor cells via cytokines and chemokines, as well as promote tumor progression by regulating the functions of anti-tumor immune and immunosuppressive cells. MSCs-derived extracellular vesicles (MSCs-EVs) contain part of the plasma membrane and signaling factors from MSCs; therefore, they display similar effects on tumors in the immunosuppressive TME. The tumor-promoting role of macrophage migration inhibitory factor (MIF) in the immunosuppressive TME has also been revealed. Interestingly, MIF exerts similar effects to those of MSCs in the immunosuppressive TME. In this review, we summarized the main effects and related mechanisms of tumor-associated MSCs (TA-MSCs), TA-MSCs-EVs, and MIF on tumors, and described their relationships. On this basis, we hypothesized that TA-MSCs-EVs, the MIF axis, and TA-MSCs form a positive feedback loop with tumor cells, influencing the occurrence and development of tumors. The functions of these three factors in the TME may undergo dynamic changes with tumor growth and continuously affect tumor development. This provides a new idea for the targeted treatment of tumors with EVs carrying MIF inhibitors.

Citing Articles

Fusion of tumor cells and mesenchymal stem/stroma cells: a source of tumor heterogeneity, evolution and recurrence.

Liu Z, Wang Y, Peng Z, Li H, Wang H, Wu Y Med Oncol. 2025; 42(2):52.

PMID: 39838167 DOI: 10.1007/s12032-024-02595-z.


Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients.

Talia M, Cesario E, Cirillo F, Scordamaglia D, Di Dio M, Zicarelli A J Transl Med. 2024; 22(1):597.

PMID: 38937754 PMC: 11210052. DOI: 10.1186/s12967-024-05413-2.


Cell death shapes cancer immunity: spotlighting PANoptosis.

Gao L, Shay C, Teng Y J Exp Clin Cancer Res. 2024; 43(1):168.

PMID: 38877579 PMC: 11179218. DOI: 10.1186/s13046-024-03089-6.


Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy.

Li K, Nie H, Jin R, Wu X Front Immunol. 2024; 15:1397005.

PMID: 38779660 PMC: 11109455. DOI: 10.3389/fimmu.2024.1397005.


The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma.

Li Y, Liu F Front Immunol. 2023; 14:1200249.

PMID: 37575250 PMC: 10419216. DOI: 10.3389/fimmu.2023.1200249.


References
1.
Blazquez R, Sanchez-Margallo F, de la Rosa O, Dalemans W, Alvarez V, Tarazona R . Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol. 2014; 5:556. PMC: 4220146. DOI: 10.3389/fimmu.2014.00556. View

2.
Zhang J, Zhang G, Yang S, Qiao J, Li T, Yang S . Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell. World J Surg Oncol. 2016; 14:51. PMC: 4765021. DOI: 10.1186/s12957-016-0797-5. View

3.
Yang T, Wang Y, Dai W, Zheng X, Wang J, Song S . Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity. J Hematol Oncol. 2018; 11(1):50. PMC: 5885466. DOI: 10.1186/s13045-018-0595-3. View

4.
Crain S, Robinson S, Thane K, Davis A, Meola D, Barton B . Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model. Stem Cells Dev. 2018; 28(3):212-226. DOI: 10.1089/scd.2018.0097. View

5.
Morris K, Nofchissey R, Pinchuk I, Beswick E . Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers. PLoS One. 2014; 9(6):e98656. PMC: 4041794. DOI: 10.1371/journal.pone.0098656. View